Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug discovery.

Regeneron Pharmaceuticals and Mammoth Biosciences will collaborate to research, develop and commercialize gene editing therapies for multiple diseases, the companies said on Thursday.

Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its blood cancer therapy for two forms of lymphoma on concerns over the progress of ongoing confirmatory trials.

MAHA report: 'Overmedicalization, poor diet' factors for childhood chronic diseases Bayer wins EU recommendation for label expansion of Regeneron-partnered Eylea© Provided by Seeking Alpha ...

Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron Pharmaceuticals Inc., the latest headache for one of the main manufacturing partners ...

Regeneron’s stock crashed 17% on Friday. Meanwhile, JPMorgan downgraded Cooper Companies to ‘Neutral’ from ‘Overweight,’ lowering the price target to $76 from $110.

Sanofi and Regeneron’s blockbuster drug Dupixent successfully treated patients with an inflammatory skin disease in a late-stage trial.

Kymera Therapeutics reported that an experimental drug designed to rival Sanofi and Regeneron’s blockbuster therapy Dupixent succeeded in a closely watched early-stage trial.

The biotech company President Trump credited with helping him fend off the coronavirus is run by two Queens-bred billionaires who still have roots in New York.

Wolfe Research initiated coverage of Regeneron (REGN) with an Outperform rating and $1,150 price target Eylea patent litigation concerns had pressured Regeneron from all-time highs, and the firm ...

The U.S. District Court for the District of Massachusetts has allowed part of the U.S. government's claims to proceed against Regeneron Pharmaceuticals for allegedly funneling millions of dollars ...